Pentwater Capital Management LP - ADC THERAPEUTICS SA ownership

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of ADC THERAPEUTICS SA
ValueSharesWeighting
Q4 2020$320,000
-3.0%
10,0000.0%0.00%0.0%
Q3 2020$330,00010,0000.00%
Other shareholders
ADC THERAPEUTICS SA shareholders Q1 2021
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,186,215$9,430,0005.29%
GCM Grosvenor Holdings, LLC 1,298,012$10,319,0002.33%
Redmile Group, LLC 7,512,029$59,721,0002.28%
MPM BioImpact LLC 334,384$2,658,0000.74%
Indie Asset Partners, LLC 93,989$747,0000.66%
Eventide Asset Management 1,879,959$14,946,0000.32%
Walleye Capital LLC 888,700$7,065,0000.20%
Endurant Capital Management LP 58,967$469,0000.16%
HHLR ADVISORS, LTD. 500,000$3,975,0000.08%
Matrix Capital Management Company, LP 400,000$3,180,0000.07%
View complete list of ADC THERAPEUTICS SA shareholders